Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune Nephritis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03801135
What this trial is testing

Changes in Haemostasis After Therapeutic Plasmapheresis With Citrate Anticoagulation

Who this might be right for
Humoral RejectionGuillain-Barre SyndromeMiller Fisher Syndrome+3 more
University Medical Centre Ljubljana 20
Not applicableUnknownNCT05320133
What this trial is testing

Jinghua Weikang Capsule Containing Quadruple Therapy for IgAN With Helicobacter Pylori Infection

Who this might be right for
Helicobacter Pylori Infection
Peking University First Hospital 80
Early research (Phase 1)Study completedNCT00046774
What this trial is testing

Monoclonal Antibody Treatment for Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 23
Testing effectiveness (Phase 2)Study completedNCT04145440
What this trial is testing

Trial to Assess Safety and Efficacy of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN)

Who this might be right for
Glomerulonephritis, MembranousantiPLA2R Positive
HI-Bio, A Biogen Company 31
Large-scale testing (Phase 3)Active Not RecruitingNCT04573478
What this trial is testing

Atrasentan in Patients With IgA Nephropathy

Who this might be right for
IgA NephropathyImmunoglobulin A Nephropathy
Novartis Pharmaceuticals 404
Early research (Phase 1)Study completedNCT06922305
What this trial is testing

Relative Bioavailability Study of HR19042 in Healthy Subjects

Who this might be right for
Primary IgA Nephropathy; Autoimmune Hepatitis
Jiangsu HengRui Medicine Co., Ltd. 18
Not applicableStudy completedNCT04389827
What this trial is testing

Global Kidney Patient Trials Network

Who this might be right for
Kidney Diseases
The George Institute 5,999
Not applicableActive Not RecruitingNCT05985122
What this trial is testing

New Analytic Tools for aHUS and C3G Diagnosis

Who this might be right for
Hemolytic-Uremic SyndromeMembranoproliferative GlomerulonephritisHealthy
Mario Negri Institute for Pharmacological Research 180
Not applicableUnknownNCT05667922
What this trial is testing

Prognostic Model of TAC in the Treatment of MN

Who this might be right for
Idiopathic Membranous Nephropathy
Qianfoshan Hospital 50
Testing effectiveness (Phase 2)Study completedNCT02547922
What this trial is testing

Safety and Efficacy of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Proliferative Lupus Nephritis

Who this might be right for
Lupus Nephritis
AstraZeneca 147
Not applicableUnknownNCT04058951
What this trial is testing

Plant Versus Animal Dietary Protein and the Effect on Proteinuria

Who this might be right for
Kidney InsufficiencyDiabetes MellitusDiabetes Mellitus, Type 2+6 more
Jens Rikardt Andersen 20
Not applicableNot Yet RecruitingNCT07354503
What this trial is testing

Telitacicept in the Treatment of Pediatric IgA Vasculitis-Associated Nephritis

Who this might be right for
IgAVNIgA Vasculitis
The Children's Hospital of Zhejiang University School of Medicine 300
Not applicableLooking for participantsNCT06242327
What this trial is testing

An Outcome Analysis of Primary Membranous Nephropathy

Who this might be right for
Membranous Nephropathy
Mario Negri Institute for Pharmacological Research 500
Early research (Phase 1)Study completedNCT05562362
What this trial is testing

Study to Evaluate the Pharmacokinetics of Oral Sparsentan Suspension

Who this might be right for
Healthy Subjects
Travere Therapeutics, Inc. 47
Large-scale testing (Phase 3)Study completedNCT04541043
What this trial is testing

Efficacy and Safety in Patients With Primary IgA Nephropathy Who Have Completed Study Nef-301 (Nefigard-OLE)

Who this might be right for
Primary IgA Nephropathy
Calliditas Therapeutics AB 119
Post-approval studies (Phase 4)Ended earlyNCT01316133
What this trial is testing

Evaluate the Efficacy and Safety of Tacrolimus With Steroid in Korean Lupus Nephritis Patients

Who this might be right for
Lupus Nephritis
Astellas Pharma Korea, Inc. 37
Early research (Phase 1)Enrolling By InvitationNCT07038447
What this trial is testing

KITE-363 in Participants With Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusLupus NephritisSystemic Sclerosis+1 more
Kite, A Gilead Company 52
Testing effectiveness (Phase 2)Study completedNCT02550652
What this trial is testing

Evaluate the Safety and Efficacy of Obinutuzumab Compared With Placebo in Participants With Lupus Nephritis (LN)

Who this might be right for
Lupus Nephritis
Hoffmann-La Roche 126
Testing effectiveness (Phase 2)Looking for participantsNCT07582133
What this trial is testing

A Trial to Evaluate the Long-term Safety and Tolerability of HRS-5965 in Patients With Primary IgA Nephropathy

Who this might be right for
Primary IgA Nephropathy
Chengdu Suncadia Medicine Co., Ltd. 380
Not applicableLooking for participantsNCT07575347
What this trial is testing

Periodontal Disease in Rare Renal Disorders (PERIO-RA-RE)

Who this might be right for
Periodontal DiseasePeriodontitisCKD+6 more
Stefan Lujinschi 100
Next Page